Compound class:
Synthetic organic
Comment: BCH070 is an antimalarial drug candidate, that with further optimization shows promise as a combination therapy with artemisinin to treat multidrug-resistant malaria [1].
|
|
BCH070 has been tagged as relevant to malaria pharmacology and is awaiting detailed curation for the Guide to MALARIA PHARMACOLOGY. |